Please login to the form below
Tiziana Life Sciences
This page shows the latest Tiziana Life Sciences news and features for those working in and with pharma, biotech and healthcare.
Tiziana to develop intranasal foralumab for type 1 diabetes
Tiziana Life Sciences has announced that it is initiating a programme to develop its intranasal foralumab to treat or prevent type 1 diabetes. ... Earlier this month, Tiziana also announced plans to investigate intranasal foralumab for the treatment of
Latest news
-
Tiziana’s foralumab shows continued clinical improvement in secondary progressive MS
Tiziana Life Sciences (Tiziana) has announced that the second patient with non-active secondary progressive multiple sclerosis (SPMS) receiving intranasal foralumab has shown ‘additional clinical improvement’ after 11 months of treatment.
-
Tiziana completes enrolment of first patient cohort in MS expanded access programme
Tiziana Life Sciences (Tiziana) has completed the enrolment of the first patient cohort in its intermediate size patient population expanded access programme to evaluate foralumab in non-active Secondary Progressive Multiple ... Tiziana said that on 12
-
Tiziana starts enrolment in secondary progressive MS expanded access programme
Tiziana Life Sciences (Tiziana) has announced the start of enrolment of the first patient cohort in its intermediate size patient population expanded access programme to evaluate foralumab in non-active secondary ... Tiziana's Scientific Advisory Board,
-
Tiziana’s Foralumab shows promise in second patient with secondary progressive MS
Tiziana Life Sciences (Tiziana) has announced that the second patient with non-active secondary progressive multiple sclerosis (SPMS) has shown ‘continued clinical improvement’ after six months of dosing with intranasal Foralumab. ... Based on these
-
Tiziana announces Brigham and Women’s hospital will receive ALS Association grant
Tiziana Life Sciences (Tiziana) has announced that the Ann Romney Center for Neurologic Diseases at the Brigham and Women’s hospital (BWH) will receive a grant to study the use of ... Gabriele Cerrone, executive chairman and interim chief executive
More from news
Approximately 6 fully matching, plus 1 partially matching documents found.
Latest Intelligence
-
Taking a lean and careful approach
Kunwar Shailubhai on why biotech is a roller coaster and how Tiziana Life Sciences is pursuing its mission to tackle unmet needs. ... At 58 years old, he is still shuttling between the US and the UK as the London-based company, Tiziana Life Sciences,
More from intelligence
Approximately 1 fully matching, plus 0 partially matching documents found.
Latest appointments
-
Dr Kunwar Shailubhai appointed CEO of Tiziana Life Sciences
London, UK-based biotechnology group Tiziana Life Sciences has appointed its non-executive director Dr Kunwar Shailubhai as chief executive officer and chief scientific officer. ... He said: “This is a crucial time to be taking on this new role with
-
Tiziana Life Sciences appoints clinical sciences VP
Dr Robert Evans joins the UK biotechnology firm. London-based Tiziana Life Sciences has appointed Dr Robert Evans as its new vice president of clinical sciences. ... James Tripp, chief operating officer at Tiziana Life Sciences, said: “Bob's extensive
More from appointments
Approximately 2 fully matching, plus 0 partially matching documents found.
Subscribe to our email news alerts
- AstraZeneca and Daiichi Sankyo share positive results from phase 3 breast cancer study
- ICR and Merck renew strategic alliance for development of new cancer drugs
- DeepMind’s AI tool classifies effects of mutations in genetic diseases
- CDC awards over $23m to Johns Hopkins Center for Health Security project
- Looking to start activity on a currently unpromoted pharmaceutical brand?
- Considering a portfolio review?
No results were found
PMHub
Innovative Trials
Innovative Trials is a leading global clinical trial patient recruitment company. With over 10 years’ of experience, Innovative Trials deploys...
Latest intelligence
- The importance of accelerating clinical trial diversity
- Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
- Digital Opinion Leaders: The Role of Influencers in Medical Communications
- There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
- Creating Hope Though Action – World Suicide Prevention Day
- At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....
